Location: | London |
---|---|
Salary: | £38,082 to £45,622 per annum, inclusive of London Allowance. |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 29th January 2025 |
---|---|
Closes: | 19th February 2025 |
Job Ref: | 5013 |
Contact Details: Charlotte Hagan-Boyle, Centre Administrator, bci-ho-pa@qmul.ac.uk
About the Role
Postdoctoral Research Assistant to join Dr Gallipoli’s team (https://www.bartscancer.london/staff/dr-paolo-gallipoli/). We study the biological mechanisms underpinning myeloid leukaemia development, progression and therapy resistance with a strong focus on the role of metabolism (Dembitz, Leukemia 2024;Woodley, Nature Communication 2023&Gallipoli, Blood 2018). The successful applicant will investigate how microenvironmental and organismal metabolism affects leukemia cell intrinsic targetable dependencies with the aim to improve current therapeutics efficacy.
Informal enquiries are highly encouraged.
About You
We are seeking highly-motivated researchers holding or near completion of a PhD in a relevant biological or life sciences subject. The ability to develop independent insights into the project, solve complex problems and willingness to work flexibly within a team to achieve the project demands are needed. Experience with flow cytometry, primary cell culture, molecular biology, animal work, metabolic/transcriptional profiling is highly desirable.
About Institute
The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
The post is based at the Centre for Haemato-Oncology, Barts Cancer Institute. It is full time, fixed term for 12 months, with an expected start date of April 2025. The starting salary will be Grade 4 (SP 26-33), in the range of £38,082 - £45,622 per annum, inclusive of London Allowance. Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Closing Date: 19/02/2025, 23:55
Type / Role:
Subject Area(s):
Location(s):